Primary prevention of venous thromboembolism

Venous thromboembolism (VTE) is the most common cause of preventable in-hospital mortality and all hospitalized patients should be VTE risk assessed. The VTE risk should be weighed up against risk of bleeding on an individualized basis to guide choice of prophylaxis. The most common method of mechan...

Full description

Saved in:
Bibliographic Details
Published in:Phlebology 2012-04, Vol.27 (2_suppl), p.23-32
Main Authors: Figueiredo, R S, Stansby, G, Bhattacharya, V
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c339t-a81e3433fe09ee61e2e21fd16dbc5c6766a42f35711e02ebe4d97167bce120fc3
cites cdi_FETCH-LOGICAL-c339t-a81e3433fe09ee61e2e21fd16dbc5c6766a42f35711e02ebe4d97167bce120fc3
container_end_page 32
container_issue 2_suppl
container_start_page 23
container_title Phlebology
container_volume 27
creator Figueiredo, R S
Stansby, G
Bhattacharya, V
description Venous thromboembolism (VTE) is the most common cause of preventable in-hospital mortality and all hospitalized patients should be VTE risk assessed. The VTE risk should be weighed up against risk of bleeding on an individualized basis to guide choice of prophylaxis. The most common method of mechanical thromboprophylaxis is graduated compression stockings, although others, such as intermittent pneumatic devices, are available. Stockings have the greatest benefit when used in combination with pharmacological prophylaxis. However, stockings are contraindicated in some patients, including those with stroke or peripheral arterial disease. Various options for pharmacological thromboprophylaxis are available. The most commonly used agents are the low-molecular-weight heparins, but newer orally active agents may play an increasing role in the future.
doi_str_mv 10.1258/phleb.2012.012s32
format article
fullrecord <record><control><sourceid>sage_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1258_phleb_2012_012s32</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1258_phleb.2012.012s32</sage_id><sourcerecordid>10.1258_phleb.2012.012s32</sourcerecordid><originalsourceid>FETCH-LOGICAL-c339t-a81e3433fe09ee61e2e21fd16dbc5c6766a42f35711e02ebe4d97167bce120fc3</originalsourceid><addsrcrecordid>eNp9j8FKxDAQhoMoWFcfwFsfwNZM0iTtURZ1hQU97J5Dm07cLm1Tkq7g25u1nj38zMDwDf9HyD3QHJgoH6dDj03OKLA8JnB2QRJQoswgni9JQpksMy6EuCY3IRwppUwplZCHD98Ntf9OJ49fOM6dG1Nn07i6U0jng3dD4zCm78JwS65s3Qe8-5srsn953q032fb99W39tM0M59Wc1SUgLzi3SCtECciQgW1Bto0RRiop64JZLhQAUoYNFm2lQKrGIDBqDV8RWP4a70LwaPW0tNRA9VlX_-rqs65edCOTL0yoP1Ef3cmPseI_wA_Jblk5</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Primary prevention of venous thromboembolism</title><source>SAGE</source><creator>Figueiredo, R S ; Stansby, G ; Bhattacharya, V</creator><creatorcontrib>Figueiredo, R S ; Stansby, G ; Bhattacharya, V</creatorcontrib><description>Venous thromboembolism (VTE) is the most common cause of preventable in-hospital mortality and all hospitalized patients should be VTE risk assessed. The VTE risk should be weighed up against risk of bleeding on an individualized basis to guide choice of prophylaxis. The most common method of mechanical thromboprophylaxis is graduated compression stockings, although others, such as intermittent pneumatic devices, are available. Stockings have the greatest benefit when used in combination with pharmacological prophylaxis. However, stockings are contraindicated in some patients, including those with stroke or peripheral arterial disease. Various options for pharmacological thromboprophylaxis are available. The most commonly used agents are the low-molecular-weight heparins, but newer orally active agents may play an increasing role in the future.</description><identifier>ISSN: 0268-3555</identifier><identifier>EISSN: 1758-1125</identifier><identifier>DOI: 10.1258/phleb.2012.012s32</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><ispartof>Phlebology, 2012-04, Vol.27 (2_suppl), p.23-32</ispartof><rights>2012 SAGE Publications</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c339t-a81e3433fe09ee61e2e21fd16dbc5c6766a42f35711e02ebe4d97167bce120fc3</citedby><cites>FETCH-LOGICAL-c339t-a81e3433fe09ee61e2e21fd16dbc5c6766a42f35711e02ebe4d97167bce120fc3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>313,314,780,784,792,27922,27924,27925,79364</link.rule.ids></links><search><creatorcontrib>Figueiredo, R S</creatorcontrib><creatorcontrib>Stansby, G</creatorcontrib><creatorcontrib>Bhattacharya, V</creatorcontrib><title>Primary prevention of venous thromboembolism</title><title>Phlebology</title><description>Venous thromboembolism (VTE) is the most common cause of preventable in-hospital mortality and all hospitalized patients should be VTE risk assessed. The VTE risk should be weighed up against risk of bleeding on an individualized basis to guide choice of prophylaxis. The most common method of mechanical thromboprophylaxis is graduated compression stockings, although others, such as intermittent pneumatic devices, are available. Stockings have the greatest benefit when used in combination with pharmacological prophylaxis. However, stockings are contraindicated in some patients, including those with stroke or peripheral arterial disease. Various options for pharmacological thromboprophylaxis are available. The most commonly used agents are the low-molecular-weight heparins, but newer orally active agents may play an increasing role in the future.</description><issn>0268-3555</issn><issn>1758-1125</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNp9j8FKxDAQhoMoWFcfwFsfwNZM0iTtURZ1hQU97J5Dm07cLm1Tkq7g25u1nj38zMDwDf9HyD3QHJgoH6dDj03OKLA8JnB2QRJQoswgni9JQpksMy6EuCY3IRwppUwplZCHD98Ntf9OJ49fOM6dG1Nn07i6U0jng3dD4zCm78JwS65s3Qe8-5srsn953q032fb99W39tM0M59Wc1SUgLzi3SCtECciQgW1Bto0RRiop64JZLhQAUoYNFm2lQKrGIDBqDV8RWP4a70LwaPW0tNRA9VlX_-rqs65edCOTL0yoP1Ef3cmPseI_wA_Jblk5</recordid><startdate>20120401</startdate><enddate>20120401</enddate><creator>Figueiredo, R S</creator><creator>Stansby, G</creator><creator>Bhattacharya, V</creator><general>SAGE Publications</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20120401</creationdate><title>Primary prevention of venous thromboembolism</title><author>Figueiredo, R S ; Stansby, G ; Bhattacharya, V</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c339t-a81e3433fe09ee61e2e21fd16dbc5c6766a42f35711e02ebe4d97167bce120fc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Figueiredo, R S</creatorcontrib><creatorcontrib>Stansby, G</creatorcontrib><creatorcontrib>Bhattacharya, V</creatorcontrib><collection>CrossRef</collection><jtitle>Phlebology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Figueiredo, R S</au><au>Stansby, G</au><au>Bhattacharya, V</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Primary prevention of venous thromboembolism</atitle><jtitle>Phlebology</jtitle><date>2012-04-01</date><risdate>2012</risdate><volume>27</volume><issue>2_suppl</issue><spage>23</spage><epage>32</epage><pages>23-32</pages><issn>0268-3555</issn><eissn>1758-1125</eissn><abstract>Venous thromboembolism (VTE) is the most common cause of preventable in-hospital mortality and all hospitalized patients should be VTE risk assessed. The VTE risk should be weighed up against risk of bleeding on an individualized basis to guide choice of prophylaxis. The most common method of mechanical thromboprophylaxis is graduated compression stockings, although others, such as intermittent pneumatic devices, are available. Stockings have the greatest benefit when used in combination with pharmacological prophylaxis. However, stockings are contraindicated in some patients, including those with stroke or peripheral arterial disease. Various options for pharmacological thromboprophylaxis are available. The most commonly used agents are the low-molecular-weight heparins, but newer orally active agents may play an increasing role in the future.</abstract><cop>London, England</cop><pub>SAGE Publications</pub><doi>10.1258/phleb.2012.012s32</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0268-3555
ispartof Phlebology, 2012-04, Vol.27 (2_suppl), p.23-32
issn 0268-3555
1758-1125
language eng
recordid cdi_crossref_primary_10_1258_phleb_2012_012s32
source SAGE
title Primary prevention of venous thromboembolism
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T21%3A18%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-sage_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Primary%20prevention%20of%20venous%20thromboembolism&rft.jtitle=Phlebology&rft.au=Figueiredo,%20R%20S&rft.date=2012-04-01&rft.volume=27&rft.issue=2_suppl&rft.spage=23&rft.epage=32&rft.pages=23-32&rft.issn=0268-3555&rft.eissn=1758-1125&rft_id=info:doi/10.1258/phleb.2012.012s32&rft_dat=%3Csage_cross%3E10.1258_phleb.2012.012s32%3C/sage_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c339t-a81e3433fe09ee61e2e21fd16dbc5c6766a42f35711e02ebe4d97167bce120fc3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rft_sage_id=10.1258_phleb.2012.012s32&rfr_iscdi=true